World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
23014
World Ranking
16698
National Ranking
550

Hélène Cavé publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hélène Cavé sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 379 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hélène Cavé D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hélène Cavé sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Hélène Cavé is affiliated with Université Paris Cité in France and has contributed extensively to research in medicine and related fields. The primary fields of study for this researcher include Medicine and Biochemistry, Genetics and Molecular Biology.

Their work spans several subfields, notably:

  • Molecular Biology
  • Genetics
  • Public Health, Environmental and Occupational Health
  • Hematology
  • Pediatrics, Perinatology and Child Health

The main topics covered in their research consist of:

  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Protein Tyrosine Phosphatases
  • Childhood Cancer Survivors' Quality of Life
  • Pancreatic function and diabetes
  • Galectins and Cancer Biology
  • Diabetes Management and Research

Hélène Cavé has published multiple papers in prominent journals. Recent representative publications include:

  • "The KMT2A recombinome of acute leukemias in 2023" (2023) in Leukemia
  • "Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia" (2021) in Leukemia
  • "Predisposition to cancer in children and adolescents" (2021) in The Lancet Child & Adolescent Health
  • "Neonatal Diabetes Mellitus" (2020) in Frontiers in Pediatrics
  • "SPRED2 loss-of-function causes a recessive Noonan syndrome-like phenotype" (2021) in The American Journal of Human Genetics

Publication venues frequented by this researcher include:

  • Leukemia
  • Blood
  • Haematologica
  • European Journal of Human Genetics
  • Pediatric Blood & Cancer

Throughout their career, Hélène Cavé has collaborated regularly with several coauthors, notably:

  • Aurélie Caye-Eude
  • Giovanni Cazzaniga
  • Chloé Arfeuille
  • André Baruchel
  • Marion Strullu

Best Publications

  • Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

    J Gabert;E Beillard;V H J van der Velden;W Bi

  • Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

    Cavé H;van der Werff ten Bosch J;Suciu S;Guidal C

  • Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

    V H J van der Velden;G Cazzaniga;A Schrauder;J Hancock

  • Activating Mutations in the ABCC8 Gene in Neonatal Diabetes Mellitus

    Andrey P. Babenko;Michel Polak;Hélène Cavé;Kanetee Busiah

  • The MLL recombinome of acute leukemias in 2017

    C Meyer;T Burmeister;D Gröger;G Tsaur

  • Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

    Tetsuya Niihori;Yoko Aoki;Yoko Narumi;Giovanni Neri

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • New insights to the MLL recombinome of acute leukemias

    C. Meyer;E. Kowarz;J. Hofmann;A. Renneville

  • Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

    M. Bruggemann;A. Schrauder;T. Raff;H. Pfeifer

  • Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

    Elisabetta Flex;Valentina Petrangeli;Lorenzo Stella;Sabina Chiaretti

  • Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

    Kheira Beldjord;Sylvie Chevret;Vahid Asnafi;Françoise Huguet

  • Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.

    Reuben Benjamin;Reuben Benjamin;Charlotte Graham;Charlotte Graham;Deborah Yallop;Agnieszka Jozwik;Agnieszka Jozwik

  • The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia.

    S Raynaud;H Cave;M Baens;C Bastard

  • Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype–phenotype relationships and overlap with Costello syndrome

    Caroline Nava;Nadine Hanna;Caroline Michot;Sabrina Pereira

  • Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group

    Trudy D. Buitenkamp;Shai Izraeli;Martin Zimmermann;Erik Forestier

  • Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report

    E Vilmer;Stefan Suciu;Alina Ferster;Yves Bertrand

  • IKZF1plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

    Martin Stanulla;Elif Dagdan;Marketa Zaliova;Anja Möricke

  • Kir6.2 Mutations Are a Common Cause of Permanent Neonatal Diabetes in a Large Cohort of French Patients

    Martine Vaxillaire;Céline Populaire;Kanetee Busiah;Hélène Cavé

  • Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases

    B. Kerr;M. A. Delrue;S. Sigaudy;R. Perveen

  • Genomics and drug profiling of fatal TCF3-HLF− positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

    Ute Fischer;Michael Forster;Anna Maria Rinaldi;Thomas S. Risch

Frequent Co-Authors

Alain Verloes
Alain Verloes Université Paris Cité
Stefan Suciu
Stefan Suciu European Organisation for Research and Treatment of Cancer
Giovanni Cazzaniga
Giovanni Cazzaniga University of Milano-Bicocca
Bernard Grandchamp
Bernard Grandchamp Université Paris Cité
Philippe Froguel
Philippe Froguel Imperial College London
André Baruchel
André Baruchel Université Paris Cité
Christine J. Harrison
Christine J. Harrison Newcastle University
Martin Stanulla
Martin Stanulla Hannover Medical School
Claude Preudhomme
Claude Preudhomme University of Lille
Martin Zenker
Martin Zenker Otto-von-Guericke University Magdeburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of medicine in the USA is broad, offering diverse online education options to fit varying career goals. Many students interested in healthcare seek flexibility and speed, making accelerated healthcare programs a popular choice. These programs can help you earn qualifications faster and transition into roles in healthcare administration or management.

If you have a background in nursing, there are specific pathways like asn to nurse practitioner programs designed for registered nurses with an associate degree, helping them advance to high-demand nurse practitioner roles. For those interested in holistic health, an online degree in nutrition is ideal for careers in dietetics, wellness coaching, or public health.

Working professionals often need programs that fit their busy schedules. If you’re aiming for leadership positions in healthcare, discover whats the best online mha program for working adults to help you gain advanced management skills while balancing work commitments. Whatever your pathway, these online options provide the flexibility and specialized knowledge needed for success in today’s dynamic healthcare landscape.

Best Scientists Citing Hélène Cavé

Trending Scientists

Recently Published Articles